Austar Lifesciences Salute del bilancio
Salute finanziaria criteri di controllo 3/6
Austar Lifesciences ha un patrimonio netto totale di CN¥780.6M e un debito totale di CN¥386.3M, che porta il suo rapporto debito/patrimonio netto a 49.5%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥2.1B e CN¥1.4B.
Informazioni chiave
49.5%
Rapporto debito/patrimonio netto
CN¥386.27m
Debito
| Indice di copertura degli interessi | n/a |
| Contanti | CN¥139.98m |
| Patrimonio netto | CN¥780.63m |
| Totale passività | CN¥1.36b |
| Totale attività | CN¥2.14b |
Aggiornamenti recenti sulla salute finanziaria
Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?
Mar 28
We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt
Sep 28Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden
Mar 31Is Austar Lifesciences (HKG:6118) A Risky Investment?
Apr 06Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet
Oct 24Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Mar 31Recent updates
Austar Lifesciences Limited's (HKG:6118) Share Price Boosted 32% But Its Business Prospects Need A Lift Too
Oct 16Investors Aren't Buying Austar Lifesciences Limited's (HKG:6118) Revenues
Aug 28We Think Shareholders May Want To Consider A Review Of Austar Lifesciences Limited's (HKG:6118) CEO Compensation Package
May 24Revenues Working Against Austar Lifesciences Limited's (HKG:6118) Share Price Following 30% Dive
Apr 18Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?
Mar 28Investors Still Aren't Entirely Convinced By Austar Lifesciences Limited's (HKG:6118) Revenues Despite 25% Price Jump
Feb 12Market Cool On Austar Lifesciences Limited's (HKG:6118) Revenues
Dec 22We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt
Sep 28Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden
Mar 31Austar Lifesciences Limited (HKG:6118) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Sep 19Is Austar Lifesciences (HKG:6118) A Risky Investment?
Apr 06Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet
Oct 24With EPS Growth And More, Austar Lifesciences (HKG:6118) Is Interesting
Sep 27If You Like EPS Growth Then Check Out Austar Lifesciences (HKG:6118) Before It's Too Late
May 31Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Mar 31Is Now The Time To Put Austar Lifesciences (HKG:6118) On Your Watchlist?
Mar 01Austar Lifesciences Limited (HKG:6118) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Feb 01
Are Austar Lifesciences's (HKG:6118) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 11Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Dec 21Can You Imagine How Jubilant Austar Lifesciences' (HKG:6118) Shareholders Feel About Its 191% Share Price Gain?
Dec 07Here's What Austar Lifesciences Limited's (HKG:6118) Shareholder Ownership Structure Looks Like
Nov 23Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( CN¥1.6B ) di 6118 superano le sue passività a breve termine ( CN¥1.2B ).
Passività a lungo termine: Le attività a breve termine di 6118 ( CN¥1.6B ) superano le sue passività a lungo termine ( CN¥168.6M ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: Il rapporto debito netto/patrimonio netto ( 31.5% ) di 6118 è considerato soddisfacente.
Riduzione del debito: Il rapporto debito/patrimonio netto di 6118 è aumentato da 4.1% a 49.5% negli ultimi 5 anni.
Copertura del debito: Il debito di 6118 non è ben coperto dal flusso di cassa operativo ( 5.6% ).
Copertura degli interessi: Dati insufficienti per determinare se i pagamenti degli interessi sul debito di 6118 siano ben coperti dall'EBIT.